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Abstract
Introduction We observed an oscillatory flow while ventilating
critically ill patients with the Dräger Oxylog 3000™ transport
ventilator during interhospital transfer. The phenomenon
occurred in paediatric patients or in adult patients with severe
airway obstruction ventilated in the pressure-regulated or
pressure-controlled mode. As this had not been described
previously, we conducted a bench study to investigate the
phenomenon.
Methods An Oxylog 3000™ intensive care unit ventilator and a
Dräger Medical Evita-4 NeoFlow™ intensive care unit ventilator
were connected to a Dräger Medical LS800™ lung simulator.
Data were registered by a Datex-S5™ Monitor with a D-fend™
flow and pressure sensor, and were analysed with a laptop
using S5-Collect™ software. Clinical conditions were simulated
using various ventilatory modes, using various ventilator
settings, using different filters and endotracheal tubes, and by
changing the resistance and compliance. Data were recorded
for 258 combinations of patient factors and respirator settings
to detect thresholds for the occurrence of the phenomenon and
methods to overcome it.
Results Under conditions with high resistance in pressure-
regulated ventilation with the Oxylog 3000™, an oscillatory flow
during inspiration produced rapid changes of the airway
pressure. The phenomenon resulted in a jerky inspiration with
high peak airway pressures, higher than those set on the
ventilator. Reducing the inspiratory flow velocity was effective to
terminate the phenomenon, but resulted in reduced tidal
volumes.
Conclusion Oscillatory flow with potentially harmful effects may
occur during ventilation with the Dräger Oxylog 3000™,
especially in conditions with high resistance such as small
airways in children (endotracheal tube internal diameter <6 mm)
or severe obstructive lung diseases or airway diseases in adult
patients.
Introduction
Transport ventilators, until recently, were simple flow interrupt-
ers with constant flow, allowing only a few parameters to be
changed and with no, or only very limited, alarm and monitoring
functions. These devices are still in use by emergency services
and for mechanical ventilation of critically ill patients during int-
rahospital and interhospital transport [1]. The development of
transport ventilators in recent years has introduced flow and
pressure monitoring and has enabled the setting of positive
end expiratory pressure (PEEP), inspiration to expiration ratio,
and pressure limits. This made it possible to use these devices
not only in emergency medicine, but also for transport of criti-
cally ill patients with severe lung injury. Nevertheless, the con-
tinuation of sophisticated mechanical ventilation during
transport of critically ill patients with acute lung failure often
still required the use of an intensive care ventilator. The higher
weight, the higher power consumption, and the additional
need for compressed air, as well as the larger dimensions,
make transport with conventional intensive care ventilators
more complicated and trouble-prone [2-6].
The Oxylog 3000™ transport ventilator (Dräger Medical, Best,
The Netherlands) combines the properties of a modern inten-
sive care ventilator with the advantages of a compact transport
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ventilator, such as low weight, small dimensions, and low
power consumption. The main innovation of the Oxylog 3000™
is the possibility to use pressure-controlled, pressure-limited
ventilation and pressure support.
We therefore used the Oxylog 3000™ routinely since 2002 for
interhospital transfer, but have detected an undesired oscilla-
tory flow during inspiration in paediatric patients and in adult
patients with airway obstruction. The phenomenon occurred
during pressure-regulated or pressure-limited ventilation and
was characterised by four to eight rapid changes in flow veloc-
ity. The peak airway pressure exceeded the previously set
pressure values and the phenomenon was accompanied by a
reduction in minute ventilation. The phenomenon clinically
impressed with a staccato-like breathing sound, similar to jet
ventilation, and it was sometimes possible to detect a jerky
thorax excursion during inspiration, even if the patient received
neuromuscular blocking agents. Following these experiences,
we conducted a bench study simulating different ventilator
settings and respiratory conditions with the Oxylog 3000™ in
comparison with a standard intensive care respirator – the
Evita-4 NeoFlow™ (Dräger Medical).
Materials and methods
The Oxylog 3000™ allows the setting of all common modes of
ventilation used in critically ill patients, including intermittent
positive pressure ventilation (IPPV), biphasic intermittent pos-
itive airway pressure (BIPAP), which can be used as pressure
controlled ventilation, assisted spontaneous breathing (ASB),
which is equivalent to pressure support ventilation, continuous
positive airway pressure, synchronised intermittent mandatory
ventilation, and noninvasive ventilation with leakage compen-
sation. Flow is generated and regulated by means of four mag-
netic valves. Only oxygen is required as the gas supply since
ambient air is added for adjustment of the FIO2 from 40% to
100% by means of a Venturi valve. Further adjustable param-
eters are the I:E ratio, the tidal volume (VT), the respiratory rate,
the pressure limit, the PEEP, the ramp of inspiratory flow in
BIPAP and ASB (slow, standard, fast), and the flow trigger. A
flow sensor is positioned close to the patient. The pressure
curve, the flow curve and the following parameters can be
shown on the display of the Oxylog 3000™: peak Paw, mean
Paw, plateau Paw, PEEP, expiratory VT, respiratory rate and
expiratory minute volume.
The setting of the bench study is demonstrated in Fig. 1. The
ventilators, the lung simulator, and the test laboratory were
provided by Dräger Medical™ (Vienna, Austria). Prior to per-
forming the tests, all apparatus were checked for faults and
correct function. Reusable tubing was used for both ventila-
tors. A spirometry sensor, a heat and moisture exchange filter
(DAR Tyco™ Healthcare, Mansfield, MA, USA), and an
endotracheal tube were connected between the ventilator and
the lung simulator in an airtight manner by means of the
inflated cuff, which was checked for leakage prior to the meas-
urements. The spirometry was performed with a Datex-S5™
monitor (Datex-Ohmeda™, Helsinki, Finland) with D-fend™
sensors in different sizes (paediatric, adult). This Datex-S5™
monitor is routinely used in anaesthesia and intensive care
medicine, and uses a double line sensor inserted between the
heat and moisture exchange filter and the tubing. The Datex-
S5™ monitor was connected to a laptop using specific soft-
ware (S5-Collect™, Datex-Ohmeda™, Helsinki, Finland) to
store and analyse the measured data.
The stepwise changed parameters and respirator settings of
the 258 tests are summarised in Table 1. The special combi-
nations of patient factors and respirator settings were chosen
to detect thresholds for the occurrence of the phenomenon.
All measurements in the IPPV mode were taken with a pres-
sure limit of 20 cmH2O.
The following parameters were recorded in all tests. From the
display of the ventilators, the respiratory rate, the VT, the peak
Paw, the FIO2, warnings and alarms were read and recorded
manually. The S5-Collect™ software stored the data measured
by the spirometry module, including the peak Paw, the mean
Paw, the plateau Paw, the PEEP, the intrinsic PEEP, the inspir-
atory VT, the expiratory VT, the compliance, the resistance, the
duration of inspiration and the I:E ratio.
For each measurement the Paw curve and the flow curve of six
respiratory cycles and the trend data of all measured parame-
ters were stored in a separate file. The curves were quantita-
tively analysed with Microsoft Excel™ to evaluate the duration
of the oscillations as a percentage of the inspiration time, the
frequency of the oscillations, the amplitudes of the pressure
oscillation (Paw-ampl), the amplitude of the flow oscillation, and
the maximal inspiratory flow (Figs 2 and 3). If the peak Paw was
higher than the set inspiratory pressure in the pressure-regu-
lated modes or higher than the set pressure limit in IPPV, the
difference between these values was calculated and stored as
the airway pressure overshoot (Fig. 2). The magnitude of the
Paw-ampl and the amount of the airway pressure overshoot were
used to describe the severity of the phenomenon.
Figure 1
Scheme for the experimental set-up Scheme for the experimental set-up. HME, heat and moisture exchange 
filter.Available online http://ccforum.com/content/9/4/R315
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Selected tests were performed with both the Oxylog 3000™
and the Evita-4 NeoFlow™ to validate the measurements and
to compare ventilation with the two ventilators under exactly
the same conditions. One hundred and ninety-eight tests were
performed with the Oxylog 3000™ and 60 comparative meas-
urements were taken with the Evita-4 NeoFlow™, producing a
total of 258 tests. Differences in the peak Paw, the mean Paw,
Table 1
Course of the measurements including the settings of the lung simulator and the ventilators
Compliance, 
LS800™ 
(l/cmH2O)
Resistance, 
LS800™ 
(cmH2O/l/
s)
Leak, 
LS800™
Endotrach
eal tube ID 
(mm)
HME type D-fend™ 
type
Mode FIO2 Respiratory 
rate (/min)
Tinsp (s) I:E ratio PEEP 
(cmH2O)
Pinsp 
(cmH2O)
Ramp, 
Oxylog 
3000™
VT (ml) Number 
of 
measur
ements, 
Oxylog 
3000™
Comparable 
measurements
, Evita-4 
NeoFlow™
0.010 2, 4, 8, 16, 
32, 64, 
128
No 4 Baby Paed BIPAP 0.4 20 1.5 1/1 5 20 Slow std 
fast
21 15
0.007 2, 32, 64, 
128
No 4 Baby Paed BIPAP 0.4 30 1 1/1 5 20 Slow std 
fast
12 4
0.015 2, 32, 64, 
128
No 4 baby Paed BIPAP 0.4 20 1.5 1/1 5 20 Std 4 4
0.020 2, 32, 64, 
128
No 5 Baby Paed BIPAP 0.4 20 1.5 1/1 5 20 Slow std 
fast
12 4
0.020 32 No 5 Baby Paed IPPV 0.4 20 1.5 1/1 5 180 – 
500
80
0.020 2, 8, 32, 
64, 128
No 7 Adult Adult BIPAP 0.8 20 1.5 1/1 15 35 Slow std 
fast
15 5
0.075 2, 8, 16, 
32, 64, 
128
No 7 Adult Adult BIPAP 0.8 16 1.9 1/1 10 28 Slow std 
fast
18 6
0.020 2, 8, 16, 32 No 7 Adult Adult ASB 0.8 6 20 Slow std 
fast
12 0
0.020 2, 8, 16, 32 No 7 Adult Adult CPAP 0.5 6 6 4 0
0.020 2, 8, 16, 32 No 7 Adult Adult ASB 0.5 6 20 Slow std 
fast
12 4
0.030 2, 8, 16, 
32, 64, 
128
No 7 Adult Adult BIPAP 0.5 12 1.6 1/2 8 26 Slow std 
fast
18 6
0.020 2, 8, 16, 
32, 64, 
128
No 7 Adult Adult BIPAP 0.5 12 1.6 1/2 8 26 Slow std 
fast
18 6
0.020 2 no 5 Paed Paed BIPAP 0.5 20 1.2 1/1.5 5 20 Slow std 
fast
30
0.020 2 Yes 5 Paed Paed BIPAP 0.5 20 1.2 1/1.5 5 20 Slow std 
fast
30
0.020 2 no 5.5 Paed Paed BIPAP 0.5 20 1.2 1/1.5 5 20 Slow std 
fast
30
0.020 2 Yes 5.5 Paed Paed BIPAP 0.5 20 1.2 1/1.5 5 20 Slow std 
fast
30
0.020 2 No 6 Paed Paed BIPAP 0.5 20 1.2 1/1.5 5 20 Slow std 
fast
30
0.020 2 Yes 6 Paed Paed BIPAP 0.5 20 1.2 1/1.5 5 20 Slow std 
fast
30
0.020 2 Yes 5 Paed Paed BIPAP 0.5 20 1.2 1/1.5 5 20 Std 1 0
0.020 2 Yes 5 Paed Paed BIPAP 0.4, 0.6, 
0.8, 1
20 1.2 1/1.5 5 20 Fast 4 0
0.020 2 Yes 5 Paed Paed BIPAP 0.4, 0.6, 
0.8, 1
20 1.2 1/1.5 5 20 Std 4 0
0.020 2 Yes 5 Paed Paed IPPV 0.5 20 1.2 1/1.5 5 240 – 
600
80
0.020 2 No 5 Paed Paed IPPV 0.5 20 1.2 1/1.5 5 180 – 
600
90
Related test-series with changes in one or maximal two parameters are grouped in one row. Numbers are values of the set parameters and do not 
reflect measured results. ID, internal diameter; Tinsp = inspiration time; I:E = inspiration to expiration time ratio; PEEP = positive end expiratory 
pressure; Pinsp, = set inspiratory airway pressure; VT = tidal volume; Paed, paediatric; std, standard; BIPAP = biphasic intermittent positive airway 
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and the expiratory VT  between the two ventilators were
calculated.
The maximal inspiratory flow velocity seemed to have an impor-
tant influence on the occurrence and severity of the phenome-
non, and we therefore calculated the ratio of the maximal flows
between the Oxylog 3000™ and the Evita-4 NeoFlow™.
Statistics
As indicated by Kolmogorov-Smirnov tests, the data showed
deviations from a normal distribution, thus precluding the com-
putation of parametric descriptive and inference statistics.
Results are thus presented as the median with the interquartile
range, minimum and maximum, and the Spearman rank corre-
lations were computed. The Mann-Whitney U test was used to
examine the differences between the Oxylog 3000™ and the
Evita-4 NeoFlow™. P ≤  0.05 was considered significant.
Figure 2
Airway pressure oscillation (Paw) Airway pressure oscillation (Paw). Typical oscillatory Paw curve of the Oxylog 3000™ (solid line) in comparison with the Evita-4 NeoFlow™ (broken 
line). Settings: endotracheal tube internal diameter, 5 mm; biphasic intermittent positive airway pressure, 20/5 cmH2O; respiratory rate, 20/min; 
inspiration to expiration time ratio, 1:1; ramp, fast. The maximal amplitude of the pressure oscillation is the airway pressure amplitude (Paw-ampli-
tude). Paw-overshoot, airway pressure overshoot.
Figure 3
Flow curve oscillation Flow curve oscillation. Typical oscillatory flow curve of the Oxylog 3000™ (solid line) in comparison with the Evita-4 NeoFlow™ (broken line), with the 
same settings as Fig. 1. The minimal flow was calculated by dividing the expiratory tidal volume, measured by the Oxylog 3000™, through the time of 
inspiration.Available online http://ccforum.com/content/9/4/R315
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Results
No oscillatory flow was detected in any test using the Evita-4
NeoFlow™ respirator. Overall with the Oxylog 3000™, an oscil-
latory flow was detected in 90% of all respective
measurements. The phenomenon was seen in the pressure-
regulated modes BIPAP, ASB, continuous positive airway
pressure, and in pressure-limited IPPV. No significant differ-
ence in the expiratory VT was detected when comparing the
Oxylog 3000™ measurements with oscillatory inspiratory flow
with the corresponding Evita-4 NeoFlow™ tests. Nevertheless,
the oscillations resulted in significant higher peak and mean
Paw on comparing the two ventilators (Table 2).
The duration and the shape of the pressure oscillations
depended on the mode, on the ramp, and on whether a leak-
age was simulated. In general the curve oscillated around the
normally seen Paw curve, which could be observed in compar-
ison with the Paw  curve of the Evita-4 NeoFlow™
measurements.
It was possible to measure the frequency of the oscillations in
153 tests with a median frequency of 5 Hz(interquartile range,
1.25 Hz; minimum, 2.78 Hz; maximum, 12.5 Hz). There was a
trend to lower frequencies of the oscillations when the phe-
nomenon was more severe. In the tests with a measured fre-
quency of 4.17 Hz the median Paw-ampl was 23.8 cmH2O, with
a frequency of 5 Hz the median was 15.8 cmH2O, and with a
frequency of 12.5 Hz the median Paw-ampl was 6.9 cmH2O.
Concerning the severity of the phenomenon, the median val-
ues of Paw-ampl and the amount of the airway pressure over-
shoot are summarised in Table 3.
The severity of the phenomenon increased when the resist-
ance on the LS800™ lung simulator (Dräger Medical, Best,
The Netherlands) was increased (Fig. 4). The steepness of the
ramp, set on the Oxylog 3000™, correlated positively with the
severity of the oscillations (Fig. 5).
Changing the compliance on the LS800™ lung simulator did
not have any influence on the occurrence and severity of the
phenomenon. This was also true for the respiratory rate, the
PEEP, the time of inspiration, and the I:E ratio. An intrinsic
PEEP was detected in 126 of the Oxylog 3000™ measure-
ments but did not show any correlation to the phenomenon.
No influence of the set FIO2 on the occurrence of the phenom-
enon was seen. The phenomenon also occurred with 100%
oxygen when the Venturi valve was not active.
We investigated the differences between the maximal inspira-
tory flow velocities generated by the two ventilators. The flow
generated by the Oxylog 3000™ was usually higher than that
with the Evita-4 NeoFlow™. The ratio of the maximal flows
between the Oxylog 3000™ and the Evita-4 NeoFlow™ corre-
lated well to the severity of the phenomenon, expressed as
Paw-ampl (Fig. 6).
The oscillations almost exclusively occurred during inspiration.
In general, the flow pattern of the expirations was no different
Table 2
Comparison between measurements showing oscillatory inspiratory flow andcorresponding Evita-4 NeoFlow™ measurements.
Parameter n Median P value
Oxylog 3000™ Evita-4 NeoFlow™
Peak airway pressure (cmH2O) 40 32.65 20.8 <0.001
Mean airway pressure (cmH2O) 40 13.05 12.1 0.007
Expiratory tidal volume (ml) 40 133.05 136.35 0.840
Peak inspiratory flow (l/s) 40 16.05 11.85 0.023
Only tests with biphasic intermittent positive airway pressure and without leakage were included.
Table 3
Severity of the phenomenon
Parameter Median Interquartile range Minimum Maximum n
Pressure amplitude (cmH2O) 12.15 17.75 0.10 37.9 153
Flow amplitude (l/s) 13.35 27.33 0.10 63.8 153
Airway pressure overshoot (cmH2O) 6.6 12.53 0.10 27.6 128Critical Care    Vol 9 No 4    Frank et al.
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compared with the corresponding Evita-4 NeoFlow™ meas-
urements. An oscillatory flow during expiration was only seen
in some of the measurements with simulated leakage, when
the ventilator had to generate a flow directed to the test lung
during expiration to maintain the PEEP. The oscillations during
expiration had a Paw-ampl of 5 cmH2O and a frequency of 4.17
Hz. In comparison with equivalent measurements without leak-
age there seemed to be an attenuating effect of the leakage on
the severity of the inspiratory oscillations.
Discussion
While no oscillatory flow could be detected with the Evita-4
NeoFlow™, the phenomenon was found in a high percentage
of tests with the Oxylog 3000™. We have to point out, how-
ever, that this high percentage is due to the setting of our
tests, chosen to induce and investigate the phenomenon. Fifty
per cent of the tests were taken with small endotracheal tubes,
and the phenomenon was surprisingly seen in all tests with
endotracheal tubes with internal diameter ≤  6 mm in pressure-
regulated modes, irrespective of the test lung conditions. Only
five tests with endotracheal tubes of internal diameter ≤  6 mm
showed no oscillatory flow, and all of them were taken in the
IPPV mode without reaching the pressure limit (constant flow).
Two parameters had an impact on the occurrence and severity
of the phenomenon: the resistance, and the peak velocity of
the inspiratory flow. The latter is influenced by the ramp set on
the Oxylog 3000™ and by the interaction of test lung
conditions and ventilator settings. The ratio of the maximal
inspiratory flow measured with the Oxylog 3000™ to the max-
Figure 4
Influence of the test lung – resistance Influence of the test lung – resistance. Stepwise increase of the resistance on the LS800™ lung simulator resulted in an increase of the amplitude of 
the airway pressure oscillations (Paw-amplitude) as well as in an increase in the airway pressure overshoot (Paw-overshoot), defined as peak airway 
pressure minus the upper pressure limit.
Figure 5
Influence of the steepness of the ramp on the phenomenon Influence of the steepness of the ramp on the phenomenon. A stepwise increase of the ramp, set on the Oxylog 3000™, resulted in an increase of 
the amplitude of the airway pressure oscillations (Paw-amplitude) as well as in an increase in the airway pressure overshoot (Paw-overshoot), 
defined as the peak airway pressure minus the upper pressure limit.Available online http://ccforum.com/content/9/4/R315
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imal flow measured with the Evita-4 NeoFlow™ is another way
to describe an inappropriate high flow at the beginning of the
inspiration, and the value correlated well to the severity of the
phenomenon.
The following hypothesis was made to explain why an oscilla-
tory flow occurs under conditions with high resistance and
high initial flow. The maximal inspiratory flow, reached during
pressure-regulated ventilation, mainly depends on the airway
resistance. The initial flow generated by the Oxylog 3000™ in
the BIPAP and ASB modes depends on the ramp, and in the
mode of pressure-limited IPPV it depends on the set VT. The
flow, initially generated by the Oxylog 3000™, sometimes is
much higher than the flow that can traverse the resistance set
on the test lung. After initiation of the inspiration with an inap-
propriate high flow, the inspiratory pressure or the pressure
limit (set on the Oxylog 3000™) is reached very rapidly and the
flow is downregulated or stopped by the Oxylog 3000™. This
does not occur rapidly enough and the Paw exceeds the target
value. The pressure drops after the reduction or interruption of
the flow and the flow is generated too late and too high again.
Thus the pressure oscillates around the desired level. The
oscillations are a result of rapid changes between exceedingly
high and low flow velocities. The feedback mechanism
between measured Paw and flow generation does not work
rapidly enough or sensitively enough to smoothly adjust the
inspiratory flow to an appropriate level.
We might explain the expiratory oscillation, seen in some
measurements with a simulated leakage, by the fact that dur-
ing expiration the leakage has to be compensated by a flow
delivered by the Oxylog 3000™ to maintain the PEEP.
The results of the bench study predict a high probability for the
phenomenon to occure in paediatric patients with narrow
airways. This is exactly what we have seen in clinical practice.
The phenomenon occurred frequently in paediatric patients
and it was not possible to use BIPAP in patients with an
endotracheal tube < 6 mm ID. The mode had to be changed
to IPPV, but an inspiratory oscillatory flow still occurred in the
IPPV when the pressure limit was active. We adjusted the VT
carefully to avoid an oscillatory flow, on the one hand, and to
avoid low minute ventilation, on the other.
You would not expect the Paw to be higher than that set on the
ventilator in a pressure-regulated or pressure-limited mode,
but exactly this happens when an oscillatory flow occurs.
Unfortunately we have not measured the pressures in the test
lung, but the following points led to our conclusion that the
phenomenon is potentially dangerous and harmful. There is an
airway pressure overshoot, the mean airway pressure is
increased and the peak airway pressure may reach values
above 50 cmH2O. The oscillations led to a jerky inspiration,
showing that the pressure spikes really do reach the lung.
Finally the pressure limit of the Oxylog 3000™ does not pro-
tect against the pressure overshoot.
The phenomenon of oscillatory inspiratory flow may impose as
a malfunction of the device but it actually reflects a kind of
limitation, of which the user should be aware and know how to
deal with. We informed Dräger Medical in The Netherlands
about our experiences and the results of the bench study. In
the meantime, Dräger Medical started their own measure-
ments and confirmed the validity of the problem. An adaptation
of the operator's manual of the Oxylog 3000™ seems neces-
Figure 6
Peak inspiratory flow Peak inspiratory flow. Correlation between the airway pressure amplitude (Paw-amplitude) and the ratio of the peak inspiratory flow with the Oxylog 
3000™ to the peak inspiratory flow with the Evita-4 NeoFlow™ (flow-ratio ox/ev). Only measurements in the biphasic intermittent positive airway pres-
sure or the intermittent positive pressure ventilation modes without leakage and without single spikes in the flow curve were included.Critical Care    Vol 9 No 4    Frank et al.
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sary, especially because the Oxylog 3000™ is licensed for
ventilation with a very low VT (≥  50 ml).
Limitations
Spirometry was not obtained by a pneumotachograph, but
with a spirometry module normally used for clinical purpose.
This may especially affect the measurements of the compli-
ance and the resistance, particularly in the tests with an oscil-
latory flow. Nevertheless, the flow curves and pressure curves
obtained with this device were of good quality, and the results
of the VT and other parameters were in accordance with the
values displayed by the ventilators.
Conclusion
Under conditions with high resistance an oscillatory inspiratory
flow may occur during ventilation with the Oxylog 3000™ in the
BIPAP, ASB, continuous positive airway pressure, and pres-
sure-limited IPPV modes. The phenomenon results in elevated
airway pressures and jerky inspiration. The unexpected high
airway pressures may be potentially harmful, and therefore
ventilation should be checked for the phenomenon in paediat-
ric patients with narrow endotracheal tubes and in adult
patients with severe obstructive airway or lung disease. If
oscillations are present, the ventilator setting has to be
adjusted by reducing the steepness of the ramp in BIPAP and
ASB or by reducing the VT in pressure-limited IPPV.
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Key messages
•  An oscillatory flow during inspiration may occur in pres-
sure-regulated modes with the Oxylog 3000™, espe-
cially when airway resistance is high.
•  The oscillatory flow results in a jerky inspiration and in 
elevated airway pressures.
•  Peak airway pressures are markedly elevated above the 
set upper pressure limit and may cause lung injury.